New - European Medical Journal

Continue

News

EMJ
Cardiology
27 Apr 2016

Celyad Receives Certification for C-Cure® Non-Clinical Data from the European Medicines Agency (EMA)

C-Cure® (C3BS-CQR-1) is a cardiovascular lineage-committed cell therapy product being developed for the treatment of ischemic heart failure
EMJ
Urology
26 Apr 2016

Introducing EMJ Urology 4.1

United Kingdom, April 21, 2016: This edition of the EMJ Urology eJournal, as in previous editions, is full of the latest news, reviews, interviews, and…
EMJ
Cardiology
25 Apr 2016

Physical Exercise Combats Depression Post Heart Attack

UNIQUE data has shed light on the mental health of individuals who have experienced a heart attack. The analysis, which used the data collected from…
EMJ
Cardiology
25 Apr 2016

Functional Cardiac Muscle Cells can be Successfully Regenerated

BIOENGINEERED human hearts are becoming a reality after a team of researchers successfully generated cardiomyocytes (cardiac muscle cells)…
EMJ
Hematology
21 Apr 2016

New Congress on Thrombosis and Haemostasis

Amsterdam, The Netherlands: The very first ECTH will be held at the World Forum in The Hague, The Netherlands, from 28 – 30 September 2016.
EMJ
Oncology
21 Apr 2016

MammaPrint Genetic Test Can Reduce Use of Post-Surgery Chemotherapy among Early-Stage Breast Cancer Patients

NEW ORLEANS — Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological…
EMJ
General Healthcare
21 Apr 2016

Norgine Expands Its Partnership with Apharm to Commercialise ZIVEREL® in New European Countries

LONDON, 15 April 2015, 07:00 AM BST: Norgine B.V. announced today that it has expanded its agreement with Apharm s.r.l. to distribute ZIVEREL® in…
EMJ
Cardiology
21 Apr 2016

Heart Attack Patients More Depressed but Get Less Antidepressants

Athens, Greece – 16 April 2016: Heart attack patients are more depressed but are less often prescribed antidepressants than people who have not had a…